MeSH term
Frequency | Condition_Probility | Animals | 15 | 0.0 |
Cell Line | 4 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
Humans | 17 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Rats | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Female | 3 | 0.0 |
Gene Expression/drug effects/immunology | 2 | 5.0 |
Male | 3 | 0.0 |
RNA, Messenger/drug effects/metabolism | 2 | 1.0 |
COS Cells | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Trans-Activators/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Binding Sites | 2 | 0.0 |
Dimerization | 2 | 0.0 |
Mice | 7 | 0.0 |
Models, Molecular | 3 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Comparative Study | 4 | 0.0 |
Corticotropin/secretion | 2 | 3.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Pro-Opiomelanocortin/genetics | 2 | 11.0 |
Interleukin-6/*metabolism/pharmacology | 2 | 11.0 |
Base Sequence | 5 | 0.0 |
Genetic Markers | 2 | 0.0 |
Receptor, Ciliary Neurotrophic Factor | 6 | 6.0 |
Ciliary Neurotrophic Factor | 2 | 1.0 |
*Disease Models, Animal | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
*Chromosomes, Human, Pair 9 | 3 | 1.0 |
Crosses, Genetic | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Hominidae/*genetics | 2 | 1.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Transfection | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |